Explain this page
Arphra AIPlain-English read on The Allstate Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +24.72% | +11.22% | +12.67% | +22.83% | +33.23% | +23.37% | +23.34% | +23.52% |
| Operating margin | +13.28% | -3.62% | -0.61% | +9.07% | +19.80% | +9.60% | +9.65% | +9.30% |
| EBITDA margin | +16.19% | -1.28% | +1.30% | +10.57% | +21.12% | +10.68% | +10.81% | +11.29% |
| EBIT margin | +13.96% | -2.95% | +0.05% | +9.70% | +20.40% | +9.77% | +10.13% | +9.81% |
| Pre-tax margin | +13.28% | -3.62% | -0.61% | +9.07% | +19.80% | +9.32% | +9.64% | +9.61% |
| Net margin | +3.32% | -2.55% | -0.33% | +7.35% | +15.47% | +7.64% | +7.59% | +7.43% |
| Cost structure | ||||||||
| Cost of revenue / sales | +75.28% | +88.78% | +87.33% | +77.17% | +66.77% | +78.24% | +76.05% | +76.42% |
| R&D intensity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A intensity | -1.32% | +0.23% | +0.02% | -0.06% | -0.05% | -0.03% | -0.03% | -0.03% |
| Effective tax rate | +19.98% | — | — | +20.17% | +21.97% | +20.94% | +21.17% | +20.65% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +6.42% | -7.42% | -1.07% | +21.84% | +33.61% | +21.19% | +20.41% | +20.01% |
| Return on assets (ROA) | +1.62% | -1.32% | -0.18% | +4.18% | +8.59% | +4.23% | +4.16% | +4.24% |
| Return on capital (ROC) | +19.53% | -7.23% | -1.36% | +19.56% | +34.55% | +19.68% | +19.43% | +18.81% |
| Return on invested capital (ROIC) | +4.88% | -5.42% | -1.02% | +15.85% | +27.00% | +15.66% | +15.29% | +15.03% |
| Asset turnover | +48.95% | +51.66% | +54.75% | +56.90% | +55.50% | +55.42% | +54.82% | +56.99% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +3.32% | -2.55% | -0.33% | +7.35% | +15.47% | +7.64% | +7.59% | +7.43% |
| Asset turnover (× revenue / assets) | +48.95% | +51.66% | +54.75% | +56.90% | +55.50% | +55.42% | +54.82% | +56.99% |
| Equity multiplier (× assets / equity) | +395.75% | +564.36% | +586.28% | +522.38% | +391.51% | +500.86% | +490.38% | +472.32% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 0.49 | 0.52 | 0.55 | 0.57 | 0.55 | 0.55 | 0.55 | 0.57 |
| Fixed-asset turnover | 51.84 | 51.28 | 65.88 | 94.94 | 106.00 | — | — | — |
| Inventory turnover | — | — | — | — | — | — | — | — |
| Receivables turnover | 2.65 | 2.69 | 3.00 | 3.25 | 3.21 | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 137.87 | 135.45 | 121.60 | 112.28 | 113.59 | — | — | — |
| Days inventory outstanding (DIO) | — | — | — | — | — | — | — | — |
| Days payables outstanding (DPO) | — | — | — | — | — | — | — | — |
| Cash conversion cycle | 137.87 | 135.45 | 121.60 | 112.28 | 113.59 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 3.17 | -3.97 | -22.49 | 1.91 | 0.98 | 1.65 | 1.62 | 1.68 |
| FCF / Net income | 2.96 | -3.65 | -21.07 | 1.87 | 0.96 | 1.56 | 1.60 | 1.60 |
| FCF margin | +9.80% | +9.29% | +7.00% | +13.73% | +14.87% | +11.89% | +12.19% | +11.92% |
| OCF margin | +10.51% | +10.12% | +7.47% | +14.06% | +15.21% | +12.58% | +12.32% | +12.50% |
| CapEx / Revenue | +0.71% | +0.83% | +0.47% | +0.33% | +0.34% | +0.37% | +0.37% | +0.39% |
| CapEx / D&A | 0.32 | 0.50 | 0.38 | 0.38 | 0.47 | — | — | — |
| Stock-based comp / Revenue | +0.26% | +0.20% | 0.00% | 0.00% | 0.00% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 17.25 | -5.03 | -1.20 | 16.99 | 38.19 | 29.64 | 26.13 | 25.45 |
| EPS · basic | 17.50 | -5.03 | -1.20 | 17.22 | 38.68 | 29.98 | 26.73 | 26.03 |
| Book value / share | 84.01 | 64.02 | 67.16 | 79.79 | 115.56 | 85.76 | 91.23 | 93.82 |
| Tangible BV / share | 67.55 | 46.77 | 50.14 | 64.85 | 78.39 | 85.76 | 91.23 | 93.82 |
| Sales / share | 162.75 | 186.64 | 215.58 | 237.17 | 251.08 | 238.04 | 245.27 | 252.57 |
| Operating CF / share | 17.10 | 18.88 | 16.11 | 33.35 | 38.19 | 29.95 | 30.21 | 31.57 |
| Free cash flow / share | 15.95 | 17.33 | 15.09 | 32.57 | 37.33 | 28.29 | 29.89 | 30.10 |
| Dividends / share | 2.96 | 3.41 | 3.52 | 3.59 | 3.91 | 3.67 | 3.89 | 4.05 |
| Payout ratio | +54.83% | -71.84% | -492.02% | +20.61% | +10.08% | +20.20% | +20.87% | +21.57% |
| Retention ratio | +45.17% | +171.84% | +592.02% | +79.39% | +89.92% | +79.80% | +79.13% | +78.43% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +3.98% | +11.80% | +12.24% | +4.64% | -6.03% | +4.48% | +1.59% | +4.51% |
| Gross profit · YoY | — | -52.82% | +26.33% | +102.18% | +52.32% | -33.92% | +4.34% | +2.35% | +3.77% |
| Profit | |||||||||
| Operating income · YoY | — | -128.30% | +80.98% | +1755.46% | +128.36% | -54.43% | +5.01% | -2.06% | -0.68% |
| EBITDA · YoY | — | -108.22% | +213.43% | +813.74% | +109.01% | -52.49% | +5.74% | +6.11% | -0.74% |
| Net income · YoY | — | -179.86% | +85.42% | +2582.45% | +120.31% | -53.63% | +3.91% | -0.58% | +17.28% |
| Operating | |||||||||
| EBIT · YoY | — | -122.00% | +102.07% | +19774.19% | +120.01% | -55.01% | +8.38% | -1.61% | -0.63% |
| R&D · YoY | — | — | — | — | — | — | — | — | — |
| Per-share | |||||||||
| EPS · diluted · YoY | — | -129.16% | +76.14% | +1515.83% | +124.78% | -22.38% | -11.85% | -2.62% | +5.71% |
| EPS · basic · YoY | — | -128.74% | +76.14% | +1535.00% | +124.62% | -22.48% | -10.84% | -2.63% | +5.84% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $7.98B | $7.96B | $7.94B | $8.09B | $7.49B | $7.96B | $8.13B | $8.15B |
| Net debt | $7.21B | $7.23B | $7.22B | $7.38B | $6.81B | $7.26B | $7.4B | $7.4B |
| Net debt / EBITDA | 0.92 | -11.15 | 9.82 | 1.10 | 0.49 | 1.09 | 1.05 | 0.99 |
| Debt / equity | 0.32 | 0.46 | 0.45 | 0.38 | 0.24 | 0.35 | 0.33 | 0.33 |
| Debt / assets | +8.02% | +8.13% | +7.68% | +7.24% | +6.25% | +7.06% | +6.83% | +7.01% |
| Equity / assets | +25.27% | +17.72% | +17.06% | +19.14% | +25.54% | +19.97% | +20.39% | +21.17% |
| Coverage | ||||||||
| EBITDA / interest expense | 23.88 | -1.93 | 1.94 | 16.79 | 35.18 | 16.56 | 17.05 | 17.92 |
| Operating income / interest | 19.59 | -5.46 | -0.92 | 14.40 | 32.97 | 14.89 | 15.23 | 14.77 |
| Interest expense | $330M | $335M | $379M | $400M | $399M | $402.63M | $413.44M | $417.51M |
| Liquidity | ||||||||
| Current ratio | — | — | — | — | 0.37 | — | — | — |
| Quick ratio | — | — | — | — | 0.37 | — | — | — |
| Cash ratio | — | — | — | — | 0.01 | — | — | — |
| Working capital | $23.16B | $23.69B | $24.72B | $24.78B | -$44.69B | — | — | — |
| Working capital / revenue | +47.58% | +46.81% | +43.68% | +39.01% | -67.24% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).